1.
COVID-19 rapid guideline: haematopoietic stem cell transplantation
Anonymous,
National Institute for Health and Care Excellence. 2020;07:29-29
Abstract
The purpose of this guideline is to maximise the safety of patients who need haemopoietic stem cell transplantation and make the best use of NHS resources, while protecting staff from infection On 29 July 2020, we amended recommendations on advice and testing for COVID-19 for patients and donors, and removed recommendations on deferring treatment for some patients to reflect changes in the risk of infection and the capacity in services See update information for details Follow the usual professional guidelines, standards and laws (including those on equalities, safeguarding, communication and mental capacity), as described in making decisions using NICE guidelines This guideline is for: health and care practitioners;health and care staff involved in planning and delivering services;commissioners;donor registries It covers haemopoietic stem cell transplantation in adults, children and young people The recommendations bring together: existing national and international guidance and policies;advice from specialists working in the NHS from across the UK These include people with expertise and experience of treating patients for the specific health conditions covered by the guidance during the current COVID-19 pandemic We developed this guideline using the interim process and methods for developing rapid guidelines on COVID-19 in response to the rapidly evolving situation We will review and update the recommendations as the knowledge base develops using the interim process and methods for guidelines developed in response to health and social care emergencies